Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1

Conditions

Breast Neoplasms 6Squamous Cell Carcinoma of Head and Neck 3Head and Neck Neoplasms 3Sarcoma, Kaposi 2Neoplasm Metastasis 2Lymphoma, Non-Hodgkin 2Colonic Neoplasms 2Uterine Cervical Dysplasia 1Ulcer 1Tongue Neoplasms 1Stomatitis 1Skin Neoplasms 1Shoulder Injuries 1Shoulder Dislocation 1Salivary Gland Neoplasms 1Salivary Gland Adenoma, Pleomorphic 1Radiodermatitis 1Radiation Injuries 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parasomnias 1Papillomavirus Infections 1Meningococcal Infections 1Melanoma 1Margins of Excision 1Lymphoma 1Lymphedema 1Lung Neoplasms 1Kidney Transplantation 1Joint Instability 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Has results × Salivary Gland Adenoma, Pleomorphic × Clear all
NCT02013180 2019-04-16

Zinc/PSA Ratio as a Novel Biomarker for Prostate Cancer Detection

Bagcilar Training and Research Hospital

Completed
480 enrolled 6 charts
GenitourinaryHead & Neck

Salivary Gland Adenoma, Pleomorphic, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡